Darmiyan's BrainSee nabs breakthrough status from FDA

By AuntMinnie.com staff writers

June 2, 2021 -- The U.S. Food and Drug Administration (FDA) has granted breakthrough status to Darmiyan's artificial intelligence (AI)-based software, BrainSee, which detects Alzheimer's disease from MRI scans.

BrainSee detects Alzheimer's disease at the early stage of mild cognitive impairment using a brain MRI. The scan does not require an injection or radiation. The software will enable clinicians to select patients who are in the early stages of neurodegeneration for clinical trials, paving the way for potential new therapies and treatments.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: